In such studies, it has been speculated that, in the absence of cardiac insulin resistance, the hyperinsulinemia that accompanies type 2 diabetes at some point along the progression of the disease could contribute to cardiomyocyte hypertrophy, given the known action of insulin as an anabolic hormone involved in cell growth. This evidence concerns the gene INS and type 2 diabetes mellitus.